New Texas law allows for MD compensation for school telehealth visits

A new law means physicians participating in Texas' Medicaid program will receive compensation for virtual appointments with children at school.

The law goes into effect on Sept. 1, according to an article published in the Texas Tribune. Children enrolled in Medicaid would be able to meet remotely with a doctor while under the supervision of a school nurse. The doctor would assess the child's condition with the use of an electronic stethoscope, digital otoscope and other tools.

Rep. Jodie Laubenberg (R-Parker) wrote the legislation and said that if the doctor makes a diagnosis, the child can be treated at school so parents don't have to leave work to pick up their children. Laubenberg said she wrote the legislation to support telemedicine programs.

Criticism includes questions about how schools will determine who is eligible for virtual doctor visits, making sure the virtual doctor is adequately informed about the patient's history and allergies and making sure patients who sign blanket consent forms understand the implications.

  

 

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.